Uncategorized

Clinical Evaluation Reports (CER) & Post-Market Surveillance (PMS) Plans in ICELAND

Published on November 10, 2026 By

Navigating the complex regulatory landscape for chemical solutions, specialty water treatment formulations, and medical devices in the European Economic Area (EEA) requires precise, compliant documentation. Water Chemicals Solution (Alkemist) provides end-to-end authoring and technical maintenance of Clinical Evaluation Reports (CER) and Post-Market Surveillance (PMS) Plans customized specifically for market entry and continuous compliance in Iceland.

Applicable Regulations in ICELAND

As a member of the European Economic Area (EEA), Iceland aligns its medical and chemical regulatory frameworks directly with European Union directives and regulations, enforced locally by competent authorities such as the Icelandic Medicines Agency (Lyfjastofnun) and the Environment Agency of Iceland (Umhverfisstofnun).

Our regulatory experts ensure your documentation strictly complies with:

  • Regulation (EU) 2017/745 (EU MDR): Full compliance with Annex XIV for Clinical Evaluation Reports (CER) and Annex III / Articles 83–86 for Post-Market Surveillance (PMS) Plans, Periodic Safety Update Reports (PSUR), and Post-Market Clinical Follow-up (PMCF).
  • Biocidal Products Regulation (EU) No 528/2012 (BPR): Applicable to medical-grade disinfectants, sanitizers, and specialty water treatment chemical devices operating on the border of medical and biocidal classifications in Iceland.
  • Regulation (EC) No 1272/2008 (CLP): Harmonized hazard classification, labeling, and packaging standards enforced by Umhverfisstofnun for chemical preparations and clinical reagents.
  • Act on Medical Devices No. 132/2020: National Icelandic legislation transposing EU MDR requirements for local distribution, authorized representation, and vigilance reporting.

What We Deliver for ICELAND

Alkemist offers comprehensive compliance packages engineered to accelerate market authorization while guaranteeing strict technical alignment with Icelandic and EEA standards.

  • Fast Turnaround Execution: Rapid authoring of CERs (MDR Annex XIV) and PMS Plans (MDR Article 84) by certified medical writers and chemical safety experts, keeping your commercial timelines on track.
  • Localized Language Variants: Fully compliant technical documents authored in English with localized Icelandic (Íslenska) language variants for Safety and Clinical Performance summaries (SSCP), hazard statements, user instructions, and patient-facing documentation.
  • Export-Ready & Submission-Compliant Files: Complete eCTD-ready technical dossiers, structured perfectly for direct submission to Lyfjastofnun, notified bodies, and Icelandic customs clearance agencies.
  • Post-Market Infrastructure: Robust PMS Plans, PMCF Protocols, and Trend Reporting workflows designed for continuous real-world data collection within Iceland’s healthcare network.

Local Challenges We Solve

Distributing specialty chemical solutions, clinical reagents, or medical products in Iceland presents unique administrative and logistical obstacles. Alkemist eliminates regulatory friction by solving local challenges proactively:

  • Customs & Import Delays: Customs authorities at Keflavík and Reykjavík ports enforce strict verification of chemical hazard data and medical regulatory status. We construct export-ready dossiers that prevent hold-ups at the border.
  • Hazard Phrasing Differences: Micro-variations in hazard translation (CLP/GHS) between generic EU templates and Icelandic national requirements can cause immediate rejection. We ensure 100% localized accuracy in hazard phrasing and precautionary statements.
  • Dual Agency Oversight: Borderline products—such as specialized water treatment systems for hemodialysis or medical surface disinfectants—often require cross-compliance between Lyfjastofnun (medical) and Umhverfisstofnun (environmental/biocide). We harmonize your CER and PMS files to satisfy both agencies simultaneously.
  • Small-Market Data Limitations: Gathering localized post-market clinical data in smaller population centers can be difficult. Our PMS plans utilize scalable PMCF survey strategies tailored specifically for low-volume EEA markets.

Start Your Request

Ensure your chemical solutions and medical technologies achieve uninterrupted market access in Iceland. Partner with Water Chemicals Solution (Alkemist) for audit-ready Clinical Evaluation Reports and Post-Market Surveillance Plans.

To launch your project or request a detailed regulatory consultation, contact our compliance team directly at:

Email: admin@alkemist.org